Buchler Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is QUININE SULFATE, USP, with a corresponding US DMF Number 17086.
Remarkably, this DMF maintains an Active status since its submission on January 05, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 24, 2013, and payment made on June 14, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II